State Street Corp Edesa Biotech, Inc. Transaction History

State Street Corp

  • $2.25 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.8 - $8.05 $15,840 - $159,390
19,800 Added 81.9%
43,975 $94,000
Q2 2022

Aug 15, 2022
BUY
$1.47 - $2.94 $1,911 - $3,822
1,300 Added 5.68%
24,175 $39,000
Q4 2021

Feb 14, 2022
BUY
$5.17 - $8.65 $46,530 - $77,850
9,000 Added 64.86%
22,875 $129,000
Q3 2021

Nov 15, 2021
BUY
$4.2 - $11.92 $58,275 - $165,390
13,875 New
13,875 $102,000

About Edesa Biotech, Inc.

EDSA Quotes by TradingView
  • Ticker EDSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,462,300
  • Market Cap $38.2M
  • Description
  • Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...
More about EDSA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email